Ogino, M; Naiki, T; Orui, H; Kosone, K; Yamazaki, M. Study of method for identifying phenethylamine drugs JCCL, 11 Feb 2011, 50, 63-82. 627 kB. Japanese, English abstract LC,MS,NMR,IR
Fond, G; Howes, O. Pharmacoterrorism: the potential role of psychoactive drugs in the Paris and Tunisian attacks Psychopharmacology, 1 Mar 2016, 233 (6), 933-935. 256 kB. https://doi.org/10.1007/s00213-016-4204-2
Calderon, SN; Klein, M. A regulatory perspective on the abuse potential evaluation of novel stimulant drugs in the United States Neuropharmacology, 1 Dec 2014, 87, 97-103. 266 kB. https://doi.org/10.1016/j.neuropharm.2014.04.001
Bork, W; Dahlenburg, R; Gimbel, M; Jacobsen-Bauer, A; Zörntlein, S. Herleitung Von Grenzwerten Der „nicht Geringen Menge“ Im Sinne Des Btmg Toxichem Krimtech, 1 Jan 2019, 86 (1), 5–91. 4.4 MB. #PP-035
Elliott, SP; Holdbrook, T; Brandt, SD. Prodrugs of new psychoactive substances (NPS): A new challenge J. Forensic Sci., 13 Jan 2020, 65 (3), 913-920. 815 kB. https://doi.org/10.1111/1556-4029.14268 #Fenethylline MS,UV
Musshoff, F. Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine Drug Metab. Rev., 2 Jan 2017, 32 (1), 15–44. 376 kB. https://doi.org/10.1081/DMR-100100562